Kite founder’s new firm inks off-the-shelf CAR T deal with Pfizer
Newly formed company Allogene Therapeutics has teamed with Pfizer to develop allogeneic CAR T-cell therapies.
Newly formed company Allogene Therapeutics has teamed with Pfizer to develop allogeneic CAR T-cell therapies.
Process control, quality management and training operators are areas where biomanufacturers can learn from small molecule makers, according to preliminary results from a BioPlan Associates survey.